Evidence map›Paper›PMID 28249896›Full record

ArticleCancer research2017

Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment.

Sobeyda B Gomez-Chou, Agnieszka Katarzyna Swidnicka-Siergiejko, Niharika Badi, Myrriah Chavez-Tomar, Gregory B Lesinski, Tanios Bekaii-Saab, Matthew R Farren, Thomas A Mace, Carl Schmidt, Yan Liu and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it, 169 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Lipocalin-2 and intestinal diseases.World journal of gastroenterology · 2024
    Review
  19. Select Endocrine Disorders and Exosomes in Early PDAC Diagnosis.International journal of molecular sciences · 2024
    Review
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Sobeyda B Gomez-ChouDepartment of Cancer Biology, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Agnieszka Katarzyna Swidnicka-SiergiejkoDepartment of Cancer Biology, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Niharika BadiDepartment of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Myrriah Chavez-TomarDepartment of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Gregory B LesinskiDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
Tanios Bekaii-SaabDepartment of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, Arizona.
Matthew R FarrenDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
Thomas A MaceDepartment of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Carl SchmidtDepartment of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Yan LiuDepartment of Cancer Biology, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Defeng DengDepartment of Cancer Biology, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Rosa F HwangDepartment of Surgical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Liran ZhouDepartment of Surgical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Todd MooreDepartment of Surgical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Deyali ChatterjeeDepartment of Pathology, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Huamin WangDepartment of Pathology, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Xiaohong LengDepartment of Translational Molecular Pathology, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Ralph B ArlinghausDepartment of Translational Molecular Pathology, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Craig D LogsdonDepartment of Cancer Biology, University of Texas, MD Anderson Cancer Center, Houston, Texas. zobeida.cruz-monserrate@osumc.edu clogsdon@mdanderson.org.
Zobeida Cruz-MonserrateDepartment of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio. zobeida.cruz-monserrate@osumc.edu clogsdon@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USThe Ohio State University Wexner Medical Center · USEmory University · USBialystok University of Technology · PLMayo Clinic in Arizona · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
MOLECULAR MECHANISMS OF PANCREATITISR01DK052067 · NIDDK · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LOGSDON, CRAIG D · 1998 to 2015
$4.4M
NCI NIH HHS P30 CA016058NCI NIH HHS P30 CA016672NIDDK NIH HHS R01 DK052067
6 · The paper itself

Abstract

Lipocalin-2 (LCN2) promotes malignant development in many cancer types. LCN2 is upregulated in patients with pancreatic ductal adenocarcinoma (PDAC) and in obese individuals, but whether it contributes to PDAC development is unclear. In this study, we investigated the effects of Lcn2 depletion on diet-induced obesity, inflammation, and PDAC development. Mice with acinar cell-specific expression of Kras

Indexed as

Tumor MicroenvironmentAnimalsCarcinoma, Pancreatic DuctalCytokinesDisease Models, AnimalGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansInflammation MediatorsKaplan-Meier EstimateLipocalin-2MiceMice, KnockoutMice, TransgenicPancreatic NeoplasmsPrognosisCytokinesInflammation MediatorsLipocalin-2RNA, Small Interfering

Identifiers

PMID28249896
PMCPMC5441230
OpenAlexW2591872758

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.